 |
DEBN
Last updated: July 31, 2024
Founders: Artur Gibas, Michał Krużycki, Marcin Sieczkowski
Poland | Funding: $377.4M (+)
Website: http://www.debn.eu/
DEBN is a medical device company developing a novel prostate biopsy needle for urologists which reduces infectious complication rate by delivering the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start.This augmented prophylaxis could save $2B cost of infections' treatment following 5M biopsies worldwide.
Website: http://www.debn.eu/
DEBN is a medical device company developing a novel prostate biopsy needle for urologists which reduces infectious complication rate by delivering the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start.This augmented prophylaxis could save $2B cost of infections' treatment following 5M biopsies worldwide.
